175 related articles for article (PubMed ID: 7075642)
1. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
Aro A; Anttila M; Korhonen T; Sundquist H
Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
[TBL] [Abstract][Full Text] [Related]
2. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
Wells PG; Feely J; Wilkinson GR; Wood AJ
Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
[TBL] [Abstract][Full Text] [Related]
3. Effects of thyroid dysfunction on propranolol kinetics.
Riddell JG; Neill JD; Kelly JG; McDevitt DG
Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675
[TBL] [Abstract][Full Text] [Related]
4. No enhanced elimination of propranolol in patients with hyperthyroidism.
Ishizaki T; Masuno M; Tawara K
Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
[TBL] [Abstract][Full Text] [Related]
5. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
[TBL] [Abstract][Full Text] [Related]
6. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
[TBL] [Abstract][Full Text] [Related]
7. Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.
Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Anttila M; Sundqvist H
Br J Clin Pharmacol; 1980 Apr; 9(4):399-405. PubMed ID: 7378257
[TBL] [Abstract][Full Text] [Related]
8. Propranolol and sotalol metabolism after a drinking party.
Sotaniemi EA; Anttila M; Rautio A; Stengård J; Saukko P; Järvensivu P
Clin Pharmacol Ther; 1981 Jun; 29(6):705-10. PubMed ID: 7226702
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
Feely J
Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
[No Abstract] [Full Text] [Related]
10. Increased clearance of propranolol in thyrotoxicosis.
Feely J; Stevenson IH; Crooks J
Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504
[TBL] [Abstract][Full Text] [Related]
11. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of sotalol during pregnancy.
O'Hare MF; Leahey W; Murnaghan GA; McDevitt DG
Eur J Clin Pharmacol; 1983; 24(4):521-4. PubMed ID: 6861867
[TBL] [Abstract][Full Text] [Related]
13. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Lemmer B; Winkler H; Ohm T; Fink M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
[TBL] [Abstract][Full Text] [Related]
14. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Perrild H; Hansen JM; Skovsted L; Christensen LK
Clin Endocrinol (Oxf); 1983 Feb; 18(2):139-42. PubMed ID: 6133659
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.
O'Connor P; Feely J
Clin Pharmacokinet; 1987 Dec; 13(6):345-64. PubMed ID: 3325214
[TBL] [Abstract][Full Text] [Related]
17. Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity.
Erkkola R; Lammintausta R; Liukko P; Anttila M
Acta Obstet Gynecol Scand; 1982; 61(1):31-4. PubMed ID: 7046334
[TBL] [Abstract][Full Text] [Related]
18. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
Wilkinson R; Burr WA
Am Heart J; 1984 Oct; 108(4 Pt 2):1160-7. PubMed ID: 6148879
[TBL] [Abstract][Full Text] [Related]
19. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
Garvey HL; Ram N
J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.
Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR
Cardiology; 1984; 71(6):307-14. PubMed ID: 6151871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
